Researchers looked at the connection between memory loss and acid reflux from prescribed medications in patients with cancer.
Some patients with cancer who experience acid reflux may be prescribed medication to help, but new research suggests an unintended side effect: impaired memory and concentration.
Proton pump inhibitors (PPIs), which help reduce acid production in the stomach, are associated with concentration and memory problems in breast cancer survivors, according to study findings published in the Journal of Cancer Survivorship. On average, cognitive problems reported by patients using the drug were between 20% and 29% more severe than issues reported by non-PPI users.
Researchers examined data from three Ohio State University clinical trials examining fatigue, a yoga intervention and vaccine response in patients and survivors of breast cancer. Patients reported their use of prescribed and over-the-counter medications, then rated any cognitive symptoms.
According to the results, PPI use predicted more severe concentration and memory symptoms and lower quality of life related to impaired cognition, regardless of whether a patient had received a diagnosis of depression or other illness, as well as their treatment, age and education.
“Based on what we’re seeing, we don’t know if PPI users might not be able to fully recover cognitively after chemotherapy,” lead author Annelise Madison, a graduate student in clinical psychology at Ohio State, said in a press release. “It’s an area for further investigation.”